Kyverna Therapeutics Inc.

1.94
-0.03 (-1.52%)
At close: Apr 04, 2025, 1:06 PM

Kyverna Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
-127.48M -60.37M -28.89M -26.35M
2.13M 1.71M 1.05M 586K
8.36M 2.22M 929K 7.25M
7.12M -659K -7.03M -5.66M
-5.12M 605K 1.41M 829K
n/a n/a n/a n/a
7.86M 3.42M -10.33M -4.49M
-114.25M -52.41M -36.11M -22.16M
-2.21M -621K -768K -1.29M
n/a n/a n/a n/a
-490M -54.85M -56.49M n/a
323.64M 46.68M 43.17M n/a
7.66M n/a -13.33M n/a
-160.9M -8.79M -14.1M -1.29M
-956K -781K -249K -41K
n/a n/a n/a n/a
n/a n/a n/a n/a
-3.1M n/a 175K 30K
337.11M 58.12M 11.88M 72.52M
61.96M -3.08M -38.33M 49.08M
-116.45M -53.03M -36.88M -23.44M